| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,803 |
8,418 |
$450K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,385 |
3,385 |
$207K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,422 |
1,406 |
$90K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,087 |
1,072 |
$42K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
504 |
504 |
$24K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,846 |
1,826 |
$18K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
408 |
403 |
$13K |
| 81025 |
|
1,675 |
1,625 |
$9K |
| 81002 |
|
2,254 |
2,198 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
490 |
469 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
24 |
24 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
188 |
101 |
$2K |
| 99201 |
|
20 |
20 |
$679.42 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
298 |
293 |
$251.91 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
28 |
28 |
$207.17 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
39 |
38 |
$141.42 |
| 87400 |
|
12 |
12 |
$86.60 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
25 |
25 |
$20.12 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
26 |
26 |
$1.61 |
| S9083 |
Global fee urgent care centers |
1,891 |
1,808 |
$0.00 |